Organon Executive and Leadership Team

Joseph Morrissey, the Chief Executive Officer at Organon, directs the overarching corporate strategy for the development and manufacturing of innovative prescription medicines. The Chief Executive Officer manages the alignment of research initiatives with global market demands to improve human health outcomes. By cultivating high-level business partnerships, Joseph Morrissey expands the reach of core therapeutic portfolios across international markets. This leadership role involves constant evaluation of the pharmaceutical landscape to ensure long-term growth and operational excellence. The Chief Executive Officer maintains rigorous oversight of organizational performance, ensuring that every division contributes to the mission of enhancing life quality. Through decisive action, the Chief Executive Officer drives the company toward sustainable success in the competitive healthcare sector. Morrissey secures the necessary resources to support large-scale manufacturing operations while maintaining strict compliance with global regulatory standards, ultimately positioning the firm as a leader in the pharmaceutical industry.

Mazen Altaruti, the President, Emerging Markets (Japan) at Organon, directs the commercial expansion and market penetration strategies within the Japanese pharmaceutical sector. The President, Emerging Markets (Japan) oversees the distribution of innovative prescription medicines, ensuring that local healthcare providers receive essential therapeutic products. By analyzing regional market trends, Mazen Altaruti adapts the company's global strategy to meet the specific needs of the Japanese population. This leadership role involves managing relationships with local regulatory bodies and healthcare partners to facilitate the adoption of new treatments. The President, Emerging Markets (Japan) coordinates with global manufacturing teams to ensure a consistent supply of high-quality medicines across the region. Altaruti drives growth by identifying untapped opportunities in the therapeutic landscape. Through strategic oversight of regional operations, the President, Emerging Markets (Japan) ensures that the company's commitment to improving human life quality remains a central focus of all activities within this critical geographic market.

Jo Snyder, the Chief of Staff at Organon, coordinates executive operations and facilitates communication across all internal departments to ensure seamless execution of corporate objectives. The Chief of Staff manages the flow of information to the leadership team, enabling rapid decision-making regarding the manufacturing and marketing of prescription medicines. By streamlining administrative processes, Jo Snyder optimizes the efficiency of the executive office. This role involves managing cross-functional projects that support the broader mission of improving human health. The Chief of Staff monitors the progress of strategic initiatives, ensuring that every department remains aligned with the overarching goals of the organization. Snyder provides critical support to the C-suite, facilitating collaboration between research, manufacturing, and commercial teams. Through meticulous planning and oversight, the Chief of Staff maintains organizational stability, allowing the company to focus on delivering high-quality therapeutic solutions to patients worldwide while navigating complex operational challenges.

Manav Maheshwari, the Chief Information Officer, Strategic Business Planning Lead, Digital & Commercial Strategy at Organon, architects the digital infrastructure required to support global pharmaceutical manufacturing and commercial operations. The Chief Information Officer, Strategic Business Planning Lead, Digital & Commercial Strategy drives the integration of advanced data analytics into the commercial strategy to identify new market opportunities. By overseeing digital transformation, Manav Maheshwari enhances the efficiency of supply chain management and product distribution. This leadership role involves aligning information technology with long-term business planning to ensure the company remains at the forefront of medical innovation. The Chief Information Officer, Strategic Business Planning Lead, Digital & Commercial Strategy manages the deployment of secure platforms that protect sensitive research data. Maheshwari ensures that digital tools empower commercial teams to reach patients effectively. Through the implementation of scalable technology solutions, the Chief Information Officer, Strategic Business Planning Lead, Digital & Commercial Strategy supports the company's mission to improve health outcomes through data-driven insights.